Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
BMJ Case Rep ; 14(4)2021 Apr 26.
Artículo en Inglés | MEDLINE | ID: covidwho-1203957

RESUMEN

This is a case report of a middle-aged man with no psychiatric history who presented with severe anxiety and psychotic symptoms from COVID-19. Following his discharge from intensive care unit, he was unable to sleep, was increasingly agitated and was observed hitting his head off the walls, causing haematomas. He remained highly anxious and developed paranoid delusions and auditory and tactile hallucinations, needing admission to a psychiatric ward. Treatment with antipsychotic medication gradually improved his symptoms in a few weeks. This case report highlights the new onset of psychosis due to COVID-19 infection. It demonstrates the importance of early identification and treatment of neuropsychiatric complications within an acute hospital setting. Furthermore, there is a need for research in this area to help in the prevention and treatment of such psychiatric complications due to COVID-19.


Asunto(s)
COVID-19/complicaciones , Deluciones/etiología , Trastornos Psicóticos/etiología , Antipsicóticos/uso terapéutico , COVID-19/psicología , Deluciones/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Trastornos Psicóticos/tratamiento farmacológico , SARS-CoV-2 , Resultado del Tratamiento
2.
Psychiatriki ; 32(1): 79-82, 2021 Apr 19.
Artículo en Inglés | MEDLINE | ID: covidwho-1148406

RESUMEN

The COVID-19 outbreak has affected millions of people globally and it also has a huge psychological impact. The objective of this case report is to outline the possible effect of the COVID-19 pandemic to the content of delusions in patients with psychosis. Α 34-year-old male with no history of mental disorder, involuntarily hospitalized due to agitation and aggression towards others, experienced grandiose delusions, referential delusions and delusions of passivity. The content of all his delusions was related to the COVID-19 pandemic. His symptoms were not proven to be caused by any physical condition or substance use disorder. He was prescribed olanzapine 10mg bd and lorazepam 2,5mg td and demonstrated significant improvement with a complete subsidence of his symptoms within a week. He was discharged after a total of 13 days with an ICD-10 diagnosis of brief psychotic disorder. At his 6 months follow-up, he reported no psychiatric symptoms. Existing literature indicates a strong relationship between life experiences and the content of delusions. This case report highlights how the stressful life event of the COVID-19 outbreak affected the content of our patient's delusions.


Asunto(s)
COVID-19/psicología , Deluciones/psicología , Pandemias , Trastornos Psicóticos/psicología , Adulto , Agresión , Ansiolíticos/uso terapéutico , Antipsicóticos/uso terapéutico , Deluciones/tratamiento farmacológico , Humanos , Internamiento Involuntario , Acontecimientos que Cambian la Vida , Lorazepam/uso terapéutico , Masculino , Olanzapina/uso terapéutico , Agitación Psicomotora , Trastornos Psicóticos/tratamiento farmacológico , Estrés Psicológico/complicaciones , Estrés Psicológico/psicología
3.
Schizophr Bull ; 47(1): 15-22, 2021 01 23.
Artículo en Inglés | MEDLINE | ID: covidwho-1045828

RESUMEN

The impact of the COVID-19 pandemic on psychosis remains to be established. Here we report 6 cases (3 male and 3 female) of first-episode psychosis (FEP) admitted to our hospital in the second month of national lockdown. All patients underwent routine laboratory tests and a standardized assessment of psychopathology. Hospitalization was required due to the severity of behavioral abnormalities in the context of a full-blown psychosis (the Brief Psychiatric Rating Scale [BPRS] = 75.8 ± 14.6). Blood tests, toxicological urine screening, and brain imaging were unremarkable, with the exception of a mild cortical atrophy in the eldest patient (male, 73 years). All patients were negative for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) throughout their stay, but 3 presented the somatic delusion of being infected. Of note, all 6 cases had religious/spiritual delusions and hallucinatory contents. Despite a generally advanced age (53.3 ± 15.6), all patients had a negative psychiatric history. Rapid discharge (length of stay = 13.8 ± 6.9) with remission of symptoms (BPRS = 27.5 ± 3.1) and satisfactory insight were possible after relatively low-dose antipsychotic treatment (Olanzapine-equivalents = 10.1 ± 5.1 mg). Brief psychotic disorder/acute and transient psychotic disorder diagnoses were confirmed during follow-up visits in all 6 cases. The youngest patient (female, 23 years) also satisfied the available criteria for brief limited intermittent psychotic symptoms. Although research on larger populations is necessary, our preliminary observation suggests that intense psychosocial stress associated with a novel, potentially fatal disease and national lockdown restrictions might be a trigger for FEP.


Asunto(s)
COVID-19/prevención & control , Control de Enfermedades Transmisibles , Deluciones , Alucinaciones , Trastornos Psicóticos , Estrés Psicológico/complicaciones , Adulto , Anciano , Antipsicóticos/administración & dosificación , Deluciones/diagnóstico , Deluciones/tratamiento farmacológico , Deluciones/etiología , Femenino , Estudios de Seguimiento , Alucinaciones/diagnóstico , Alucinaciones/tratamiento farmacológico , Alucinaciones/etiología , Humanos , Italia , Masculino , Persona de Mediana Edad , Trastornos Psicóticos/diagnóstico , Trastornos Psicóticos/tratamiento farmacológico , Trastornos Psicóticos/etiología , Inducción de Remisión , Factores de Tiempo , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA